Caring for health we create the future!

  1. Home
  2. Medicines
  3. NOBAZIT®

NOBAZIT®

  • Registration number:ЛП-003508
  • International non-proprietary name:enisamium iodide
  • Pharmaceutical form:film-coated tablets
  • Pharmacotherapeutic group:antiviral agent
  • Dosage form:tablets 250 mg No. 10

NOBAZIT® is an antiviral agent.
• It inhibits the activity of viruses causing influenza and acute respiratory viral infections
• It increases body resistance to viral infections
• It contributes to reduction of the disease duration

Indications for use:
Treatment of influenza and other acute respiratory viral infections, including that in combination therapy
Method of administration and posology:
The treatment should be started when the first disease signs appear. If there is no improvement after 3 days of treatment or the symptoms aggravate, or new symptoms occur, one should consult the doctor.
  • Nobazit® is taken orally after the meal without chewing; 0.5 g 3 times daily.
  • Maximal single dose is 1 g, and daily dose is 2 g.
  • Recommended treatment course is 5-7 days.
Manufacturer
"Moskhimfarmpreparaty" im. N. A. Semashko" LLC
THERE ARE CONTRAINDICATIONS. READ THE INSTRUCTION OR CONSULT A MEDICAL SPECIALIST BEFORE USE

We recommend

Return to the Product list